Fund HoldingsDarwin Global Management, Ltd.

Total Portfolio Value
$1.23B
Total Bought
$640.25M
Total Sold
$309.36M
Net Transaction
+$330.89M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
INSMED INC(INSM)3,541,09510,497,277+6,956,182237,076766,30162.31%+529,225
VAXCYTE INC(PCVX)2,080,9462,198,187+117,241163,916251,18720.43%+87,271
SUMMIT THERAPEUTICS INC(SMMT)01,084,880+1,084,880023,7591.93%+23,759
KEROS THERAPEUTICS INC1,525,9021,523,732-2,17068,77288,4837.20%+19,711
ELEVATION ONCOLOGY INC1,916,2900-1,916,2904,8100-4,810
GERON CORP(GERN)23,915,48022,038,773-1,876,707106,185100,0568.14%-6,129
AVIDITY BIOSCIENCES INC200,0000-200,0008,1080-8,108
SPYRE THERAPEUTICS INC(SYRE)452,0400-452,04010,2660-10,266
CORBUS PHARMACEUTICALS HLDGS325,1400-325,14014,2670-14,267
CYTOKINETICS INC(CYTK)4,575,5580-4,575,558246,0740-246,074
Page 1 of 1